3 of the protocol refers to intent ion-to-treat ( ITT) and per -protocol (PP) populations . These have been replaced throughout the SAP by All Treated Patients (ATP) analysis set and Modified Immune analysis set (MIAS) respectively. Sections 5.8.2 and 5.8.3 of the protocol define DFS and OS respectively as time from randomisation, but patients are not randomised in this study . Therefore, i n the SAP (section 6.2.1 and 6.2.2 ) this is changed to separate analyses for time from first administration of Investigational medicinal product (IMP) and time from surgery . Section 6.3.2.4 of the protocol refers to other biomarkers.